the addition of exogenous IL-2 might allow the generation of CTL.
In this paper, we show that the spleen cells from thymectomized, irradiated chimeras transplanted with bone marrow depleted of Thy-1 + cells generate in vitro H-2-restricted syngeneic and allogeneic CTL when IL-2 is added to the cultures. These Thy-I + cells bear a more immature phenotype than the spleen cells ofeuthymic mice. These results suggest that Thy-1-cells can differentiate to Thy-1 + pre-CTL by an extrathymic differentiation pathway.
Materials and Methods
Mice. C57BL/6(B6 Thy-l.2), (B6 × DBA/2)F~, (B6 × C3H)FI, and BALB/c mice come from Charles River Breeding Laboratories Inc., Wilmington, MA, or from The Jackson Laboratory, Bar Harbor, ME. 6-10-wk-old animals were used in the experiments. B6 PL Thy a/cy (B6 Thy-1.1) were bred in the Redstone Building of the Sidney Farber Cancer Institute, Boston, MA.
Thymectomy. Adult thymectomy was performed on 6-wk-old animals anesthesized with ether. The thymus was removed by vacuum aspiration. Histological evaluation of thymectomized animals did not reveal any residual thymus.
Irradiation and Reconstitution. B6 Thy-l.2 mice thymectomized 1 wk before transplant or nonthymectomized B6 mice were irradiated with a Cs Source (Gamma Cell 40, Atomic Energy of Canada, Ottawa, Canada) at 940 rad and reconstituted intravenously the same day with 2 X 107 B6 PL Thy-t a/Cy (Thy-1.1) bone marrow cells treated with anti-Thy-1.1 antibody and complement (C) (see below). Similarly, Thy-1.1 or Thy-1.2 mice were reconstituted with antiThy-l.2 antibody plus C-treated bone marrow from Thy-l.2 mice. Transplanted animals received tetracycline hydrochloride (8% solution) in their drinking water. Control animals, irradiated and nontransplanted, died in 10-13 d.
In Vitro Induction ofCytolytic TLymphocytes. Cultures were performed in 16-mm Linbro culture plates (Flow Laboratories, Inc., Rockville, MD) in 2 ml of RPMI 1640 (M. A. Bioproduets, Walkersville, MD) supplemented with 10% fetal calf serum, 2 mM L-glutamine (Gibco Laboratories, Grand Island Biological Co., Grand Island, NY), 5 × 10 -5 M 2-mercaptoethanol, penicillin (100/~g/ml), and streptomycin (100/~g/ml). 8-18 wk after transplantation, spleen cells from chimeras were used to generate primary in vitro CTL. 5 × 106 effector cells were incubated with 5 × 106 stimulator cells treated with Tris-HC1 ammonium chloride and irradiated (1,200 rad). Trinitrophenyl (TNP) stimulator cells were modified with 10 mM trinitrobenzenesulfonic acid as described previously (17) . Cultures were incubated for 5 d at 37°C in a 5% CO2 incubator.
Interleukin 2 (IL-2). The term IL-2 refers to a partially purified supernatant obtained from
Lewis rat spleen cells cultured for 24 h with concanavalin A (5 #g/ml). The fraction of the supernatant precipitated between 50% and 75% saturation of ammonium sulfate (18) was dialyzed against Tris-buffered saline, resuspended in RPMI 1640, and used in cultures at a final concentration of 5%.
Treatment of Cells With
Monoclonal Antibody and C. 50 × 10 n spleen cells or bone marrow cells were incubated for 30 min with 1 ml of a monoclonal anti-Thy-l.1 or anti-Thy-l.2 antibody (New England Nuclear, Boston, MA) at a dilution of 10 -3 in LI5 medium (M. A. Bioproducts) at room temperature. The cells were then pelleted, the supernatant discarded, and 1 ml of a 10 -1 dilution of low toxic guinea pig C was added. After 40 min at 37°C, the cells were washed, and a second treatment was performed with antibody and C at the same concentration used for the first treatment but this time added together for 40 rain at 37°C. The cells were then washed twice in L 15. This procedure was used for the following: to eliminate Thy-1-positive cells from the bone marrow before transplanting these cells to irradiated recipients, and to deplete spleen cells before stimulation in vitro or after 5 d in culture. In the latter case, 5 × l0 s cells were treated with 0.5 ml of serum and 0.5 ml of C.
Treatment of spleen cells with monoclonal anti-Ly-l.2 antibody (New England Nuclear) plus C was done twice using 25 × 10 n cells and 0.5 ml of antibody at a dilution of 4 × 10 -4, following the same procedure used for anti-Thy-1. tumor or lipopolysaccharide (LPS) lymphoblast cells, either unmodified or modified with 10 mM TNBS. LPS lymphoblasts were generated by culturing spleen cells with LPS (Difco Laboratories, Detroit, MI) at 10 ~g/ml for 48 h. The 51Cr release assay was performed as described previously (19) , with some modifications. Briefly, 5 × 10 ° target cells were labeled • 51 with 100 btCl Na2 CrO4 (New England Nuclear) for 1 h at 37°C in Eagle's minimum essential medium (MEM) supplemented with 10% fetal calf serum, penicillin and streptomycin, 1% nonessential amino acids, and 2 mM L-glutamine. Labeled cells were washed three times, and 104 cells were mixed with varying numbers of effector cells in 0.2 ml of supplemented MEM in V-bottomed plates (Linbro Chemical Co., Hamden, CT) and incubated at 37°C in 5% CO2. 100 p,l of supernatant I was harvested to determine radioactivity released. The percentage of chromium released was calculated as percent specific release: 51Cr released by immune cells51Cr released by normal cells/maximum 51Cr released (with 1% deoxycholate) -5XCr released by normal cells.
Results

Generation of Cytolytic Activity In Vitro in Thymectomized
Chimeras. Thymectomized or nonthymectomized (control) B6 Thy-l.2 mice were lethally irradiated and transplanted with bone marrow cells from the congenic strain B6 PL Thy-1 a/Cy (Thy-1.1) depleted of Thy-1-positive cells by two treatments with anti-Thy-1.1 and C (Thy-l.1 ~ Thy-l.2). Similarly, lethally irradiated B6 Thy-l.1 mice were reconstituted with treated Thy-l.2 bone marrow cells (Thy-l.2 ~ Thy-l.1). These strain combinations were chosen to minimize possible allogeneic effects but still provide the ability to assess whether cells were from the recipient or donor. 8 wk after transplantation, the spleen cells of these chimeras were assessed for their ability to generate CTL responses in vitro. When stimulated with syngeneic B6-TNP stimulator spleen cells from normal mice, good cytolytic activity was obtained against EL4-TNP by spleen cells from control chimeras, but no cytolytic activity was generated by spleen cells from thymectomized animals ( Table I ). These data agree with previous reports (5); however, when 5% IL-2 was added to the cultures, thymectomized animals generated significant cytolytic activity against syngeneic TNP-modified cells. These results were obtained both for Thy-1.1 ~ Thy-l.2 chimeras and Thy-1.2 ~ Thy-1.1 chimeras. Such results have been obtained in more than 10 experiments using different batches of chimeras transplanted 8-18 wk previously. Spleen cells from thymectomized mice co-cultured with B6 syngeneic cells did not demonstrate self reactivity, i.e., the ability to lyse EL4, even in the presence of IL-2 (Table II) . Similarly, when stimulated with allogeneic (B6 × DBA2)Fa cells, thymectomized mice generated cytolytic activity only when IL-2 was added to the culture (Table III) . In all these experiments, IL-2 alone did not have any effect (Table IV) . The use of (B6 × DBA/2)Fa stimulator cells was necessary to prevent back stimulation and IL-2 production by the irradiated stimulator cells. Bone marrow cells treated with anti-Thy-1 plus C and used to reconstitute these mice did not demonstrate any response to allogeneic or TNPmodified syngeneic cells, even in the presence of IL-2 (Table V and VI), suggesting that extrathymic differentiation had occurred in these chimeras to the point where these cells now could respond to antigen plus exogenous IL-2. thymectomized animals as well as in control chimeras (Table IV ). These results demonstrate that the functional cells in thymectomized animals are T cells and are of donor origin. In all experiments presented, splenic CTL were typed and found to be of donor origin.
Cytolytic T Lymphocytes in Chimeras
H-2 Restriction of Anti-TNP CTL in Thymectomized Chimeras.
In normal mice, anti-TNP CTL preferentially lyse autologous TNP-modified target cells but they also lyse, to a lesser degree, allogeneic TNP-coupled cells (20) . It has been proposed (5) that the thymus determines the H-2 restriction of CTL, therefore, we compared the H-2 restriction of anti-TNP CTL generated from the spleens of chimeras with or without :~ Spontaneous release for EL4 was 7% and 6-9% for EL4-TNP. § Effector-to-target ratio. II Chimeras Thy-l.1 ~ Thy-l.2 (of legend Table I ). a thymus. Table VII shows that in thymectomized animals, anti-TNP CTL lysed allogeneic TNP-modified target cells (P815-TNP) to a lesser extent than syngeneic TNP-modified targets. No difference in the H-2 restriction of anti-TNP CTL could be observed in chimeric mice with or without a thymus.
TABLE III
Generation of AUogeneic CTL from Spleen Cells of Thymectomized Chimeras
Cross-Reactivity of Alloreactive T Cells. CTL generated from normal spleen cells against aliogeneic cells cross-react on TNP-modified syngeneic cells (17) . Recently, it has been suggested that the subpopulation of allogeneic CTL that cross-react on Table I ). 11 Specific SlCr release from EL4-TNP at the indicated effector-to-target ratios. Spontaneous release of EL4-TNP was 15%. ¶ Not tested.
TNP-modified syngeneic cells is influenced by the MHC antigens on radioresistant cells in the thymus (21) . If this influence on the CTL repertoire is determined by the thymus, no cross-reactive CTL should be found in thymectomized chimeras. Table  VIII shows the cross-reactivity of anti-H-2 d CTL generated by spleen cells from B6 Thy-l.1 --~ B6 Thy-l.2 and B6 Thy-l.2 ~ B6 Thy-l.1 chimeras immunized against (B6 × DBA/2)Ft cells. The same degree of cross-reactivity by alloreactive CTL is observed on syngeneic modified EL4-TNP cells by spleen cells from thymectomized or nonthymectomized chimeras.
It has also been observed that alloreactive CTL generated from nude mice fail to demonstrate cross-reactive lysis of third-party allogeneic cells (10) , again evidence suggesting that the thymus may influence the ultimate CTL repertoire. Therefore, we investigated whether thymectomized chimeras demonstrated this cross-reactivity and found that, from thymectomized or nonthymectomized chimeras, alloreactive CTL demonstrated lysis of third-party allogeneic targets (Table IX) . IL-2 was used at a final concentration of 5%. Before culture, responder ceils were treated twice with C alone or treated twice with anti-Thy-1.1 + C. :~ Spontaneous release was 10% for P815 and 20-23% for EL4-TNP.
CTL Precursors of Thymectomized Chimeras
§ Effector-to-target ratio. However, once stimulated to become CTL, these cells again express high amounts of Thy-1. A correlation has been established between the sensitivity of cells to anti-Thy-1 plus C and the density of Thy-I antigen on their cell surface: "high Thy-l" cells are easily lysed by antibody and C (i.e., require less antibody), and "low Thy-l" are more resistant to lysis (23) . High Thy-1 is characteristic of T cells found in the thymus, and "low Thy-l" of T cells found in the spleen (24) (25) (26) . We compared the sensitivity to anti-Thy-1 treatment of splenic pre-CTL from mice with or without a thymus to determine whether different amounts of Thy-1 could be found. Results of Table X show a clear difference in the sensitivity of pre-CTL from thymectomized and nonthymectomized mice: two treatments with anti-Thy-l.1 antibody at a 10 -a dilution plus C eliminated anti-TNP CTL from the spleen cells of thymectomized animals but did not eliminate pre-C:TL from normal spleen cells or from the spleen cells of nonthymectomized chimeras. Increasing the concentration of antibody in nonthymectomized animals did not result in the elimination of pre-CTL (data not shown). Thus, the splenic pre-CTL of thymectomized mice appear to have a different phenotype from that of nonthymectomized mice; that is, they have high amounts of Thy-1 antigen, whereas the spleen cells from the nonthymectomized mice appear to express low amounts of Thy-1. Fluorescence-activated cell sorter analysis It has been demonstrated (27) that early in ontogeny, allogeneic pre-CTL are Ly-1+2 +, whereas later in development their phenotype is Ly-l±2 +, i.e., they express low amounts of the Ly-1 antigen. Therefore, if allogeneic pre-CTL from thymectomized chimeras expressed a more immature phenotype than normal pre-CTL, one might expect this to be reflected in their Lyt phenotype. Table XI demonstrates that allogeneic pre-CTL from thymectomized chimeras were very susceptible to treatment with monoclonal anti-Ly-l.2 plus C, i.e., they express the more immature Ly-l+2 + phenotype, whereas those from normal spleen and control chimeras are far less susceptible, i.e., Ly-1 ±. All pre-CTL were eliminated by treatment with monoclonal anti-Ly-2.2 plus C (data not shown). All TNP-specific pre-CTL were Ly-l+2 +, as previously described (27, 28).
TABLE VI
Lack of Reactivity of Bone Marrow Cells after
Discussion
An attempt has been made to develop a model system to study extrathymic T cell differentiation. Given the concerns surrounding the use of nude mice, we decided to use thymectomized, lethally irradiated, and bone marrow-reconstituted mice to and 35% for DBA/1 LPS blasts (experiment 1), 10% for P815, and 33% for RDM4 (experiment 2). :~ Not tested. § Chimera Thy-1.2 ~ Thy-l.l. II Chimera Thy-l.2 ~ Thy-l.2. address this issue. Though previous studies had proposed that spleen cells from such mice lacked functional T cells, based on the experience with nude mice, we proposed that IL-2 might provide the additional signal needed to drive pre-CTL to functional T cells. The results reported here are consistent with this proposal. We found that the spleens of these mice contain Thy-l-positive cells capable of becoming functional CTL recognizing alloantigens or TNP-modified syngeneic antigens when cultured with antigen and IL-2. By using Thy-1 congenic mice, we have been able to avoid allogeneic differences that might result in allogeneic effects but still have a marker to demonstrate the donor origin of the CTL generated.
There are several issues relating to extra-thymic differentiation that we have begun to address, namely, the stage of differentiation of these splenic pre-CTL and the CTL repertoire found in these thymectomized mice. By using Thy-1.1 donor cells, we have been able to easily use susceptibility to lysis by anti-Thy-1.1 plus C as a parameter to determine the state of maturation of the pre-CTL. It has been observed that thymocytes are high in Thy-1.1 expression but that peripheralized T cells, including pre-CTL, express little Thy-l.1 and, in fact, are difficult to lyse with anti-Thy-l.1 :~ Spontaneous release of EL4-TNP ranged from 7-17%. § Effector-to-target ratio. IIChimeras Thy-1.1 --~ Thy-1.2 (cf legend Table I ). ¶ 5 × l0 s spleen cells were treated twice with anti-Thy-l, l at a l0 -a dilution and complement at a dilution of 10 -I • plus C. Once stimulated with antigen to become functional CTL, these cells again are high in Thy-1.1 expression and are readily susceptible to lysis by anti-Thy-1.1 plus C (22) . The splenic pre-CTL from thymectomized mice were found to be high in Thy-l.1, which could place their stage of differentiation at that of thymocytes or mature T cells. Because thymocytes require exogenous IL-2 to respond to antigen (29, 30) and mature splenic T cells do not, it would appear that the splenic pre-CTL of thymectomized mice are at a stage of differentiation similar to that of thymocytes. The more immature Lyt phenotype of the allogeneic pre-CTL from these thymectomized chimeras is also consistent with this proposal. This suggests that in mice lacking a thymus, T cell differentiation occurs in the spleen and never reaches the stage of differentiation of normal splenic T cells; however, addition of exogenous IL-2 and antigen in vitro will allow them to differentiate to mature CTL. To be certain that our bone marrow inoculum did not contain a pre-CTL that required exogenous IL-2 to respond to antigen, we determined that, after our anti-Thy-1.1 plus C treatment, there were no pre-CTL capable of responding to antigen, even when IL-2 was added (Tables V and VI) . This would strongly suggest that differentiation to a Thy-1 + pre-CTL requiring exogenous IL-2 had occurred in these thymectomized mice.
In our initial analysis of the CTL repertoire of these mice, there are a number of similarities and several discrepancies when compared with the observations made in Table I ). :~ Effect or-t arget-rat io. § 25 × 106 spleen cells were treated twice with a monoclonal anti-Ly-l.2 antibody at a dilution of 4 × 10 -4 and complement at 10 -1 .
II Percent specific 51Cr release. Spontaneous release was 5-7% for EL4-TNP and 13% for P815.
nude mice. (a) We found the CTL generated to TNP-modified syngeneic cells to be H-2 restricted. The degree of cross-reactivity to TNP-modified allogeneic cells was similar to that reported for normal B6 mice (20) . There is, however, conflicting data concerning the H-2 restriction of nude mice. Gillis and Watson (31) have reported that the CTL generated in nude mice to TNP-modified syngeneic cells were unrestricted. Several groups, however, have reported H-2-restricted CTL generated in nude mice, including CTL generated to TNP-modified syngeneic cells (10, 11, 32) . (b) Hunig and Bevan (10) have observed that CTL generated from nude mouse spleen cells to allogeneic cells do not demonstrate cross-reactive lysis of third-party allogeneic target cells. Their data would suggest that the thymus may influence the ultimate CTL repertoire. Our thymectomized mice did demonstrate cross-reactivity and, thus, our findings are at odds with those of Hunig and Bevan. Admittedly, we examined different strain combinations, and it is possible that their strain combinations fortuitously uncovered a "hole" in the CTL repertoire that we missed. These differences, however, may reveal a difference, on a clonal level, in the T cell repertoire of nude mice compared with thymectomized mice. As we proceed with a more detailed analysis of the CTL repertoire in these mice, we might yet uncover defects or holes in their repertoire that reflect a thymic influence on the CTL repertoire.
(c) A third aspect of the CTL repertoire has also been studied and is also at odds with the observations of Hunig and Bevan (21) . Hunig and Bevan found that when (A × B)F1 mice were given an A thymus, CTL generated from these mice to alloantigen C would cross-react on A-TNP but not on B-TNP. They suggested that this demonstrated the influence of the thymus on the CTL repertoire, i.e., the crossreactivity of alloreactive CTL for TNP-modified syngeneic cells, which has been observed in normal mice (17) . Our thymectomized mice, however, did demonstrate this cross-reactivity. It has been argued that the reason (A × B)F1 mice given an A thymus respond only to A + X but not B + X is due to suppressor cells that inhibit the response to B + X. Admittedly, these suppressors have not been demonstrated, but, if such cells exist, they should also suppress the clones of CTL that were crossreactive for B-TNP, even if generated by stimulation with antigen C.
We were obviously concerned by our inability to find any holes in the T cell repertoire. Because B6 Thy-l.1 T cells express low amounts of Thy-1 antigen at certain stages of differentiation, we were concerned that some T cells recirculating to the bone marrow could escape anti-Thy-l.1 plus C treatment and account for the pre-CTL found in the spleens of the thymectomized chimeras. This, however, seems unlikely for several reasons. (a) The pre-CTL we detect in the spleens of thymectomized chimeras express high amounts ofThy-1.1 antigen, and, if such cells recirculated to the bone marrow, they should be eliminated easily with anti-Thy-l.1 plus C treatment. (b) We demonstrated that there were no detectable pre-CTL in the bone marrow inoculum after double anti-Thy-1 plus C treatment, for no cytolytic activity could be generated even when IL-2 was added with antigen (Tables V and VI) . These treated bone marrow cells also failed to proliferate to the mitogen concanavalin A (data not shown). (c) Pre-CTL from B6 Thy-1.2 --~ B6 Thy-1.1 chimeras demonstrated the same requirement for IL-2, and cross-reactive CTL was found both for the B6 Thy-l.1 ~ B6 Thy-l.2 and B6 Thy-l.2 ~ B6 Thy-l.1 chimeras (Tables I, IV , VII, VIII, and IX). B6 Thy-l.2 T cells remain susceptible to treatment by anti-Thy-l.2 plus C at all stages of their differentiation: bone marrow cells, thymocytes, splenic pre-CTL, and CTL from B6 Thy-l.2 mice and B6 Thy-l.2 --) B6 Thy-l.1 chimeras (control and thymectomized) were susceptible to anti-Thy-l.2 plus C treatment. Therefore, anti-Thy-l.2 plus C treatment of bone marrow should eliminate all Thy-l.2 T cells. (d) To be certain that we had not left a thymic remnant, we have done appropriate serial sections on thymectomized chimeras and found no thymic tissue by histological analysis. (e) The pre-CTL from our chimeras express the Lyt antigens, making it unlikely that the cytolytic activity we observed is the result of natural killer cell activity (Table XI) .
Stutman (33) has proposed that a Thy-l-negative T cell that has undergone processing in the thymus may exist. Though such a cell has not been definitively identified, such a cell could account for the discrepancies found between nude mice and our thymectomized mice. One could speculate that the reason we cannot find holes in the repertoire is that these Thy-l-negative cells are in the bone marrow inoculum given to the thymectomized, irradiated mice, and in the recipient they differentiate to express the Thy-1 marker. Experiments using fetal liver or bone marrow from nude mice are in progress to test this hypothesis. Preliminary data with fetal liver reconstituted chimeras suggest that they give similar results (data not shown).
The model system we presented here can be used to study extrathymic differentiation but it may also provide insights into the problems one might encounter in the bone marrow transplantation of patients with thymic dysfunction. For example, older transplant patients might have involuted thymuses and their thymic function might be compromised. It is important to determine whether there will only be partial immune reconstitution of these patients, i.e., they will have holes in their repertoire. If defects in their T cell repertoire occur, especially for the recognition of viruses, these patients may be at greater risk for viral infections or malignancies. If such defects are identified, perhaps the full reconstitution of their immune system may require the addition of various interleukins together with bone marrow transplantation.
Summary
A model system has been developed to study extrathymic T cell differentiation. Mice have been thymectomized, lethally irradiated, and reconstituted with bone marrow cells depleted of Thy-1-positive cells. After 8 wk, the spleen cells of these 5athymic, bone marrow-reconstituted chimeras contain Thy-l-positive pre-cytolytic T lymphocytes (CTL) that are able to respond to antigen only when exogenous interleukin 2 is added to culture. The phenotype of these pre-CTL is similar to that of thymocytes, suggesting that they may be an immature T cell. Initial evaluation of the CTL repertoire of these athymic mice demonstrates that the CTL generated to trinitrophenyl-modified syngeneic cells are H-2 restricted and that the CTL generated to alloantigens have many of the cross-reactivities observed in normal but not in nude mice. The discrepancies observed in the CTL repertoire between these thymectomized chimeras and nude mice are discussed.
